Integrating genetic regulation and schizophrenia-specific splicing quantitative expression with GWAS prioritizes novel risk genes for schizophrenia
Translational Psychiatry · 2025
DOI: 10.1038/s41398-025-03633-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Psychiatry, 2025. Verfasst von Xiaoyan Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Information Materials and Intelligent Sensing Laboratory of Anhui Province, Institute of Health Sciences and Technology, Anhui University, Hefei, Anh…. Hauptthemen laut MEDLINE: Schizophrenia, Quantitative Trait Loci, Genetic Predisposition to Disease, Alternative Splicing. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China (National Science Foundation of China).
Abstract (Originalsprache)
Alternative splicing (AS) plays a vital role in the pathogenesis of schizophrenia (SCZ). Previous studies have linked the genetic signals from genome-wide association studies (GWAS) with expression quantitative trait loci (eQTL), but the interplay with other genetic regulatory mechanisms, particularly splicing QTL (sQTL), remains unclear. Here, we constructed a comprehensive disease-specific sQTL map to provide genetic variants that could alter gene activity through RNA splicing in SCZ. We analyzed data from 539 SCZ patients, identifying a total of 24,810 significant sQTLs (FDR < 0.05) involving in AS events of 7083 unique genes. By combining this with a large-scale SCZ GWAS, we employed Mendelian randomization (MR) and colocalization analyses to pinpoint 27 significant risk genes with genetic AS regulation that may play a causal role in SCZ. Additional differential splicing analysis of these genes in 539 cases and 754 controls revealed 12 significant genes that may increase SCZ risk due to their AS dysregulation. Notably, five genes ( DPYD , LACC1 , CCDC122 , ANAPC7 , and DGKZ ) showed consistent splicing regulation effects in both MR analysis and differential splicing analysis. Pathway enrichment analysis of differentially spliced genes revealed potential biologically pathways relevant to SCZ, particularly in synaptic transmission and microtubule movement. Furthermore, single-cell RNA-seq analysis revealed that several genes were preferentially expressed in specific brain cell types, including oligodendrocytes, microglia, and excitatory neurons. Overall, our findings highlight several susceptibility genes that may contribute to SCZ risk by AS regulation. Further characterization of these genes could advance mechanistic understanding and therapeutic discovery for SCZ.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Information Materials and Intelligent Sensing Laboratory of Anhui Province, Institute of Health Sciences and Technology, Anhui University, Hefei, Anhui, China. lixiaoyan@ahu.edu.cn.
- Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence (Fudan University), Ministry of Education, Shanghai, China. lixiaoyan@ahu.edu.cn.
- Information Materials and Intelligent Sensing Laboratory of Anhui Province, Institute of Health Sciences and Technology, Anhui University, Hefei, Anhui, China.
- Department of Human Anatomy, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan, China.
- Information Materials and Intelligent Sensing Laboratory of Anhui Province, Institute of Health Sciences and Technology, Anhui University, Hefei, Anhui, China. jfxia@ahu.edu.cn.
Förderung
- National Natural Science Foundation of China (National Science Foundation of China)
Zitieren
APA
Li, X., Fan, L., Zhao, Y., Li, Y., Wang, J., Xu, S., & Xia, J. (2025). Integrating genetic regulation and schizophrenia-specific splicing quantitative expression with GWAS prioritizes novel risk genes for schizophrenia. Translational Psychiatry. https://doi.org/10.1038/s41398-025-03633-8
Vancouver
Li X, Fan L, Zhao Y, Li Y, Wang J, Xu S, et al. Integrating genetic regulation and schizophrenia-specific splicing quantitative expression with GWAS prioritizes novel risk genes for schizophrenia. Translational Psychiatry. 2025. doi:10.1038/s41398-025-03633-8
BibTeX
@article{Li2025,
author = {Li, Xiaoyan and Fan, Lingli and Zhao, Yiran and Li, Yuanyuan and Wang, Junyang and Xu, Shengmin and Xia, Junfeng},
title = {Integrating genetic regulation and schizophrenia-specific splicing quantitative expression with GWAS prioritizes novel risk genes for schizophrenia},
journal = {Translational Psychiatry},
year = {2025},
doi = {10.1038/s41398-025-03633-8}
}
EUVIMED